The role of immune checkpoint inhibitors in prostate cancer

The role of immune checkpoint inhibitors in prostate cancer

Introduction Prostate cancer (PC) is the most commonly diagnosed malignant tumour and the third cause of cancer deaths among men in Europe. The treatment of early-stage PC is very effective and in many cases allows achievement of a complete cure, whereas the treatment of metastatic prostate cancer (...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Gabriel Surdacki, Aneta Szudy-Szczyrek, Aneta Gorący, Katarzyna Chyl-Surdacka, Marek Hus
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Institute of Rural Health 2019-03-01
Seri Bilgileri:Annals of Agricultural and Environmental Medicine
Konular:
prostate cancer
checkpoint inhibitor
PD-1
PD-L1
CTLA-4
Online Erişim:http://www.journalssystem.com/aaem/The-role-of-checkpoint-Inhibitors-in-Prostate-cancer,96331,0,2.html

Internet

http://www.journalssystem.com/aaem/The-role-of-checkpoint-Inhibitors-in-Prostate-cancer,96331,0,2.html

Benzer Materyaller